Intersect ENT

169 articles about Intersect ENT

• Intersect ENT To Present At J.P. Morgan Healthcare Conference

  12/19/2014

• Intersect ENT Announces Changes To Board Of Directors

  12/11/2014

• Intersect ENT To Present At Canaccord Genuity And Piper Jaffray Conferences

  11/12/2014

• Intersect ENT Reports Third Quarter 2014 Results

  11/6/2014

• Intersect ENT Announces Publication Of Positive Data From Three Studies Of Company's Drug-Eluting Sinus Implants

  10/9/2014

• Intersect ENT Added To Russell 2000 Index

  10/2/2014

• Intersect ENT Announces Positive Data From Clinical Trial Of New In-Office Implant For Recurrent Chronic Sinusitis

  9/22/2014

• Intersect ENT Enrolls First Patient In Clinical Study To Expand Access To PROPEL Treatment To Broader Patient Population

  9/18/2014

• Intersect ENT Reports Second Quarter 2014 Results

  9/4/2014

• Intersect ENT To Announce Second Quarter Financial Results

  8/22/2014

• Study Indicates Cost Effectiveness Of Intersect ENT's PROPEL Implant For Chronic Sinusitis

  8/11/2014

• Intersect ENT Announces Closing Of Its Initial Public Offering

  7/30/2014

• Bay Area's Intersect ENT Secures $55 Million After Hitting The Low End Of Its IPO Range

  7/25/2014

• Intersect ENT To Ring The NASDAQ Stock Market Opening Bell In Celebration Of IPO

  7/24/2014

• Menlo Park's Intersect ENT Latest Health/Bio IPO To Lower Target

  7/16/2014

• Intersect ENT Announces Appointment Of Cynthia L. Lucchese To Board of Directors

  7/11/2014

• Menlo Park's Intersect ENT Files For $80 Million IPO

  6/25/2014

• Intersect ENT Announces Appointment of Chief Financial Officer Jeryl Hilleman

  6/4/2014

• Intersect ENT Announces Positive Results From Pilot Study of Novel in-Office Implant for Chronic Sinusitis Patients

  9/30/2013

• Intersect ENT Announces Positive Results From Pilot Study of Novel In-Office Implant for Chronic Sinusitis Patients

  9/30/2013